nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—ABCB1—Mitomycin—urinary bladder cancer	0.142	0.288	CbGbCtD
Nisoldipine—CYP3A4—Thiotepa—urinary bladder cancer	0.0644	0.131	CbGbCtD
Nisoldipine—CYP3A5—Etoposide—urinary bladder cancer	0.0448	0.0909	CbGbCtD
Nisoldipine—ABCB1—Gemcitabine—urinary bladder cancer	0.0408	0.0829	CbGbCtD
Nisoldipine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0399	0.0811	CbGbCtD
Nisoldipine—CYP1A2—Etoposide—urinary bladder cancer	0.0333	0.0677	CbGbCtD
Nisoldipine—ABCB1—Cisplatin—urinary bladder cancer	0.0297	0.0602	CbGbCtD
Nisoldipine—ABCB1—Etoposide—urinary bladder cancer	0.0291	0.0592	CbGbCtD
Nisoldipine—ABCB1—Doxorubicin—urinary bladder cancer	0.0199	0.0404	CbGbCtD
Nisoldipine—ABCB1—Methotrexate—urinary bladder cancer	0.0193	0.0391	CbGbCtD
Nisoldipine—CYP3A4—Etoposide—urinary bladder cancer	0.0175	0.0355	CbGbCtD
Nisoldipine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0119	0.0242	CbGbCtD
Nisoldipine—CACNA1S—seminal vesicle—urinary bladder cancer	0.00655	0.107	CbGeAlD
Nisoldipine—CYP1A2—urine—urinary bladder cancer	0.00534	0.0872	CbGeAlD
Nisoldipine—CACNB2—prostate gland—urinary bladder cancer	0.00466	0.076	CbGeAlD
Nisoldipine—CACNA2D1—prostate gland—urinary bladder cancer	0.00437	0.0714	CbGeAlD
Nisoldipine—CACNA1D—prostate gland—urinary bladder cancer	0.00407	0.0665	CbGeAlD
Nisoldipine—CYP3A4—urine—urinary bladder cancer	0.00386	0.0631	CbGeAlD
Nisoldipine—CACNA1C—prostate gland—urinary bladder cancer	0.00376	0.0614	CbGeAlD
Nisoldipine—CACNA1C—smooth muscle tissue—urinary bladder cancer	0.00266	0.0434	CbGeAlD
Nisoldipine—CACNB2—vagina—urinary bladder cancer	0.0023	0.0375	CbGeAlD
Nisoldipine—CACNA2D1—vagina—urinary bladder cancer	0.00216	0.0353	CbGeAlD
Nisoldipine—CACNA1C—female reproductive system—urinary bladder cancer	0.00205	0.0335	CbGeAlD
Nisoldipine—CACNA1C—vagina—urinary bladder cancer	0.00186	0.0303	CbGeAlD
Nisoldipine—CYP3A5—prostate gland—urinary bladder cancer	0.00185	0.0302	CbGeAlD
Nisoldipine—CACNB2—lymph node—urinary bladder cancer	0.00149	0.0243	CbGeAlD
Nisoldipine—CACNA2D1—lymph node—urinary bladder cancer	0.0014	0.0228	CbGeAlD
Nisoldipine—CYP1A2—renal system—urinary bladder cancer	0.00131	0.0213	CbGeAlD
Nisoldipine—CACNA1D—lymph node—urinary bladder cancer	0.0013	0.0212	CbGeAlD
Nisoldipine—CYP3A5—renal system—urinary bladder cancer	0.00126	0.0206	CbGeAlD
Nisoldipine—CACNA1C—lymph node—urinary bladder cancer	0.0012	0.0196	CbGeAlD
Nisoldipine—ABCB1—prostate gland—urinary bladder cancer	0.000982	0.016	CbGeAlD
Nisoldipine—CYP3A4—renal system—urinary bladder cancer	0.000946	0.0154	CbGeAlD
Nisoldipine—CYP3A5—vagina—urinary bladder cancer	0.000913	0.0149	CbGeAlD
Nisoldipine—ABCB1—seminal vesicle—urinary bladder cancer	0.000831	0.0136	CbGeAlD
Nisoldipine—CYP3A4—female reproductive system—urinary bladder cancer	0.000757	0.0124	CbGeAlD
Nisoldipine—ABCB1—epithelium—urinary bladder cancer	0.000722	0.0118	CbGeAlD
Nisoldipine—ABCB1—renal system—urinary bladder cancer	0.000669	0.0109	CbGeAlD
Nisoldipine—ABCB1—urethra—urinary bladder cancer	0.000658	0.0107	CbGeAlD
Nisoldipine—ABCB1—female reproductive system—urinary bladder cancer	0.000536	0.00875	CbGeAlD
Nisoldipine—ABCB1—vagina—urinary bladder cancer	0.000485	0.00792	CbGeAlD
Nisoldipine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000388	0.00119	CcSEcCtD
Nisoldipine—Somnolence—Fluorouracil—urinary bladder cancer	0.000387	0.00119	CcSEcCtD
Nisoldipine—Hypotension—Cisplatin—urinary bladder cancer	0.000385	0.00119	CcSEcCtD
Nisoldipine—Face oedema—Doxorubicin—urinary bladder cancer	0.000385	0.00118	CcSEcCtD
Nisoldipine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000385	0.00118	CcSEcCtD
Nisoldipine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000383	0.00118	CcSEcCtD
Nisoldipine—Gastritis—Epirubicin—urinary bladder cancer	0.000381	0.00117	CcSEcCtD
Nisoldipine—Confusional state—Etoposide—urinary bladder cancer	0.000381	0.00117	CcSEcCtD
Nisoldipine—Muscular weakness—Epirubicin—urinary bladder cancer	0.00038	0.00117	CcSEcCtD
Nisoldipine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000378	0.00116	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000376	0.00116	CcSEcCtD
Nisoldipine—Ataxia—Doxorubicin—urinary bladder cancer	0.000375	0.00115	CcSEcCtD
Nisoldipine—Dysphagia—Epirubicin—urinary bladder cancer	0.000373	0.00115	CcSEcCtD
Nisoldipine—Influenza—Epirubicin—urinary bladder cancer	0.000373	0.00115	CcSEcCtD
Nisoldipine—Asthma—Epirubicin—urinary bladder cancer	0.000373	0.00115	CcSEcCtD
Nisoldipine—Dysuria—Methotrexate—urinary bladder cancer	0.000372	0.00114	CcSEcCtD
Nisoldipine—Pruritus—Thiotepa—urinary bladder cancer	0.000372	0.00114	CcSEcCtD
Nisoldipine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00037	0.00114	CcSEcCtD
Nisoldipine—Tachycardia—Etoposide—urinary bladder cancer	0.000369	0.00113	CcSEcCtD
Nisoldipine—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000368	0.00113	CcSEcCtD
Nisoldipine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000368	0.00113	CcSEcCtD
Nisoldipine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000367	0.00113	CcSEcCtD
Nisoldipine—Dry skin—Doxorubicin—urinary bladder cancer	0.000366	0.00112	CcSEcCtD
Nisoldipine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000365	0.00112	CcSEcCtD
Nisoldipine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000365	0.00112	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000364	0.00112	CcSEcCtD
Nisoldipine—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000363	0.00112	CcSEcCtD
Nisoldipine—Anorexia—Etoposide—urinary bladder cancer	0.00036	0.00111	CcSEcCtD
Nisoldipine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00036	0.00111	CcSEcCtD
Nisoldipine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000359	0.0011	CcSEcCtD
Nisoldipine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000359	0.0011	CcSEcCtD
Nisoldipine—Hypotension—Etoposide—urinary bladder cancer	0.000353	0.00109	CcSEcCtD
Nisoldipine—Gastritis—Doxorubicin—urinary bladder cancer	0.000353	0.00109	CcSEcCtD
Nisoldipine—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000352	0.00108	CcSEcCtD
Nisoldipine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00035	0.00108	CcSEcCtD
Nisoldipine—Dysuria—Epirubicin—urinary bladder cancer	0.000348	0.00107	CcSEcCtD
Nisoldipine—Dizziness—Thiotepa—urinary bladder cancer	0.000348	0.00107	CcSEcCtD
Nisoldipine—Stomatitis—Methotrexate—urinary bladder cancer	0.000346	0.00106	CcSEcCtD
Nisoldipine—Urticaria—Fluorouracil—urinary bladder cancer	0.000346	0.00106	CcSEcCtD
Nisoldipine—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000345	0.00106	CcSEcCtD
Nisoldipine—Influenza—Doxorubicin—urinary bladder cancer	0.000345	0.00106	CcSEcCtD
Nisoldipine—Asthma—Doxorubicin—urinary bladder cancer	0.000345	0.00106	CcSEcCtD
Nisoldipine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000345	0.00106	CcSEcCtD
Nisoldipine—Pollakiuria—Epirubicin—urinary bladder cancer	0.000344	0.00106	CcSEcCtD
Nisoldipine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000344	0.00106	CcSEcCtD
Nisoldipine—Sweating—Methotrexate—urinary bladder cancer	0.00034	0.00105	CcSEcCtD
Nisoldipine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00034	0.00105	CcSEcCtD
Nisoldipine—Paraesthesia—Etoposide—urinary bladder cancer	0.000339	0.00104	CcSEcCtD
Nisoldipine—Weight increased—Epirubicin—urinary bladder cancer	0.000339	0.00104	CcSEcCtD
Nisoldipine—Haematuria—Methotrexate—urinary bladder cancer	0.000338	0.00104	CcSEcCtD
Nisoldipine—Weight decreased—Epirubicin—urinary bladder cancer	0.000337	0.00104	CcSEcCtD
Nisoldipine—Dyspnoea—Etoposide—urinary bladder cancer	0.000337	0.00104	CcSEcCtD
Nisoldipine—Somnolence—Etoposide—urinary bladder cancer	0.000336	0.00103	CcSEcCtD
Nisoldipine—Epistaxis—Methotrexate—urinary bladder cancer	0.000335	0.00103	CcSEcCtD
Nisoldipine—Rash—Thiotepa—urinary bladder cancer	0.000332	0.00102	CcSEcCtD
Nisoldipine—Dermatitis—Thiotepa—urinary bladder cancer	0.000331	0.00102	CcSEcCtD
Nisoldipine—Headache—Thiotepa—urinary bladder cancer	0.00033	0.00101	CcSEcCtD
Nisoldipine—Decreased appetite—Etoposide—urinary bladder cancer	0.000329	0.00101	CcSEcCtD
Nisoldipine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000326	0.001	CcSEcCtD
Nisoldipine—Stomatitis—Epirubicin—urinary bladder cancer	0.000324	0.000996	CcSEcCtD
Nisoldipine—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000323	0.000993	CcSEcCtD
Nisoldipine—Dysuria—Doxorubicin—urinary bladder cancer	0.000322	0.000991	CcSEcCtD
Nisoldipine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000321	0.000986	CcSEcCtD
Nisoldipine—Sweating—Epirubicin—urinary bladder cancer	0.000318	0.000979	CcSEcCtD
Nisoldipine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000318	0.000979	CcSEcCtD
Nisoldipine—Haematuria—Epirubicin—urinary bladder cancer	0.000317	0.000974	CcSEcCtD
Nisoldipine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000316	0.000973	CcSEcCtD
Nisoldipine—Weight increased—Doxorubicin—urinary bladder cancer	0.000314	0.000965	CcSEcCtD
Nisoldipine—ABCB1—lymph node—urinary bladder cancer	0.000314	0.00512	CbGeAlD
Nisoldipine—Epistaxis—Epirubicin—urinary bladder cancer	0.000313	0.000964	CcSEcCtD
Nisoldipine—Pruritus—Gemcitabine—urinary bladder cancer	0.000313	0.000963	CcSEcCtD
Nisoldipine—Nausea—Thiotepa—urinary bladder cancer	0.000313	0.000961	CcSEcCtD
Nisoldipine—Weight decreased—Doxorubicin—urinary bladder cancer	0.000312	0.000959	CcSEcCtD
Nisoldipine—Sinusitis—Epirubicin—urinary bladder cancer	0.000312	0.000958	CcSEcCtD
Nisoldipine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000311	0.000958	CcSEcCtD
Nisoldipine—Pruritus—Fluorouracil—urinary bladder cancer	0.000308	0.000947	CcSEcCtD
Nisoldipine—Visual impairment—Methotrexate—urinary bladder cancer	0.000307	0.000944	CcSEcCtD
Nisoldipine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000304	0.000935	CcSEcCtD
Nisoldipine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000303	0.000931	CcSEcCtD
Nisoldipine—Urticaria—Etoposide—urinary bladder cancer	0.0003	0.000923	CcSEcCtD
Nisoldipine—Stomatitis—Doxorubicin—urinary bladder cancer	0.0003	0.000921	CcSEcCtD
Nisoldipine—Rhinitis—Epirubicin—urinary bladder cancer	0.000299	0.000919	CcSEcCtD
Nisoldipine—Body temperature increased—Etoposide—urinary bladder cancer	0.000299	0.000919	CcSEcCtD
Nisoldipine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000299	0.000919	CcSEcCtD
Nisoldipine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000298	0.000916	CcSEcCtD
Nisoldipine—Tinnitus—Methotrexate—urinary bladder cancer	0.000297	0.000914	CcSEcCtD
Nisoldipine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000297	0.000913	CcSEcCtD
Nisoldipine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000296	0.00091	CcSEcCtD
Nisoldipine—Sweating—Doxorubicin—urinary bladder cancer	0.000295	0.000906	CcSEcCtD
Nisoldipine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000294	0.000903	CcSEcCtD
Nisoldipine—Haematuria—Doxorubicin—urinary bladder cancer	0.000293	0.000901	CcSEcCtD
Nisoldipine—Epistaxis—Doxorubicin—urinary bladder cancer	0.00029	0.000892	CcSEcCtD
Nisoldipine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000288	0.000887	CcSEcCtD
Nisoldipine—Dizziness—Fluorouracil—urinary bladder cancer	0.000288	0.000885	CcSEcCtD
Nisoldipine—Visual impairment—Epirubicin—urinary bladder cancer	0.000287	0.000884	CcSEcCtD
Nisoldipine—Chills—Methotrexate—urinary bladder cancer	0.000286	0.000879	CcSEcCtD
Nisoldipine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000282	0.000868	CcSEcCtD
Nisoldipine—Alopecia—Methotrexate—urinary bladder cancer	0.000282	0.000866	CcSEcCtD
Nisoldipine—Rash—Gemcitabine—urinary bladder cancer	0.000279	0.000858	CcSEcCtD
Nisoldipine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000279	0.000858	CcSEcCtD
Nisoldipine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000278	0.000856	CcSEcCtD
Nisoldipine—Tinnitus—Epirubicin—urinary bladder cancer	0.000278	0.000855	CcSEcCtD
Nisoldipine—Headache—Gemcitabine—urinary bladder cancer	0.000277	0.000853	CcSEcCtD
Nisoldipine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000277	0.000851	CcSEcCtD
Nisoldipine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000275	0.000844	CcSEcCtD
Nisoldipine—Rash—Fluorouracil—urinary bladder cancer	0.000274	0.000844	CcSEcCtD
Nisoldipine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000274	0.000843	CcSEcCtD
Nisoldipine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000274	0.000842	CcSEcCtD
Nisoldipine—Headache—Fluorouracil—urinary bladder cancer	0.000273	0.000838	CcSEcCtD
Nisoldipine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000272	0.000836	CcSEcCtD
Nisoldipine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000272	0.000835	CcSEcCtD
Nisoldipine—Chills—Epirubicin—urinary bladder cancer	0.000268	0.000823	CcSEcCtD
Nisoldipine—Pruritus—Etoposide—urinary bladder cancer	0.000267	0.000822	CcSEcCtD
Nisoldipine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000266	0.000818	CcSEcCtD
Nisoldipine—Alopecia—Epirubicin—urinary bladder cancer	0.000263	0.00081	CcSEcCtD
Nisoldipine—Nausea—Gemcitabine—urinary bladder cancer	0.000263	0.000809	CcSEcCtD
Nisoldipine—Rash—Cisplatin—urinary bladder cancer	0.00026	0.0008	CcSEcCtD
Nisoldipine—Dermatitis—Cisplatin—urinary bladder cancer	0.00026	0.000799	CcSEcCtD
Nisoldipine—Diarrhoea—Etoposide—urinary bladder cancer	0.000259	0.000795	CcSEcCtD
Nisoldipine—Nausea—Fluorouracil—urinary bladder cancer	0.000258	0.000795	CcSEcCtD
Nisoldipine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000257	0.000792	CcSEcCtD
Nisoldipine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000257	0.000791	CcSEcCtD
Nisoldipine—Anaemia—Methotrexate—urinary bladder cancer	0.000256	0.000789	CcSEcCtD
Nisoldipine—Flatulence—Epirubicin—urinary bladder cancer	0.000256	0.000787	CcSEcCtD
Nisoldipine—Tension—Epirubicin—urinary bladder cancer	0.000255	0.000783	CcSEcCtD
Nisoldipine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000254	0.000782	CcSEcCtD
Nisoldipine—Nervousness—Epirubicin—urinary bladder cancer	0.000252	0.000775	CcSEcCtD
Nisoldipine—Malaise—Methotrexate—urinary bladder cancer	0.00025	0.000769	CcSEcCtD
Nisoldipine—Dizziness—Etoposide—urinary bladder cancer	0.00025	0.000769	CcSEcCtD
Nisoldipine—Muscle spasms—Epirubicin—urinary bladder cancer	0.00025	0.000768	CcSEcCtD
Nisoldipine—Vertigo—Methotrexate—urinary bladder cancer	0.000249	0.000766	CcSEcCtD
Nisoldipine—Leukopenia—Methotrexate—urinary bladder cancer	0.000248	0.000764	CcSEcCtD
Nisoldipine—Chills—Doxorubicin—urinary bladder cancer	0.000248	0.000761	CcSEcCtD
Nisoldipine—Nausea—Cisplatin—urinary bladder cancer	0.000245	0.000754	CcSEcCtD
Nisoldipine—Alopecia—Doxorubicin—urinary bladder cancer	0.000244	0.00075	CcSEcCtD
Nisoldipine—Cough—Methotrexate—urinary bladder cancer	0.000242	0.000744	CcSEcCtD
Nisoldipine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000241	0.000741	CcSEcCtD
Nisoldipine—Anaemia—Epirubicin—urinary bladder cancer	0.00024	0.000738	CcSEcCtD
Nisoldipine—Rash—Etoposide—urinary bladder cancer	0.000238	0.000733	CcSEcCtD
Nisoldipine—Dermatitis—Etoposide—urinary bladder cancer	0.000238	0.000732	CcSEcCtD
Nisoldipine—Headache—Etoposide—urinary bladder cancer	0.000237	0.000728	CcSEcCtD
Nisoldipine—Flatulence—Doxorubicin—urinary bladder cancer	0.000237	0.000728	CcSEcCtD
Nisoldipine—Myalgia—Methotrexate—urinary bladder cancer	0.000236	0.000726	CcSEcCtD
Nisoldipine—Arthralgia—Methotrexate—urinary bladder cancer	0.000236	0.000726	CcSEcCtD
Nisoldipine—Chest pain—Methotrexate—urinary bladder cancer	0.000236	0.000726	CcSEcCtD
Nisoldipine—Tension—Doxorubicin—urinary bladder cancer	0.000236	0.000725	CcSEcCtD
Nisoldipine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000235	0.000723	CcSEcCtD
Nisoldipine—Malaise—Epirubicin—urinary bladder cancer	0.000234	0.00072	CcSEcCtD
Nisoldipine—Discomfort—Methotrexate—urinary bladder cancer	0.000233	0.000718	CcSEcCtD
Nisoldipine—Nervousness—Doxorubicin—urinary bladder cancer	0.000233	0.000717	CcSEcCtD
Nisoldipine—Vertigo—Epirubicin—urinary bladder cancer	0.000233	0.000717	CcSEcCtD
Nisoldipine—Syncope—Epirubicin—urinary bladder cancer	0.000233	0.000716	CcSEcCtD
Nisoldipine—Leukopenia—Epirubicin—urinary bladder cancer	0.000232	0.000715	CcSEcCtD
Nisoldipine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000231	0.00071	CcSEcCtD
Nisoldipine—Palpitations—Epirubicin—urinary bladder cancer	0.000229	0.000706	CcSEcCtD
Nisoldipine—Confusional state—Methotrexate—urinary bladder cancer	0.000228	0.000702	CcSEcCtD
Nisoldipine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000228	0.000702	CcSEcCtD
Nisoldipine—Cough—Epirubicin—urinary bladder cancer	0.000227	0.000697	CcSEcCtD
Nisoldipine—Nausea—Etoposide—urinary bladder cancer	0.000224	0.00069	CcSEcCtD
Nisoldipine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000223	0.000685	CcSEcCtD
Nisoldipine—Anaemia—Doxorubicin—urinary bladder cancer	0.000222	0.000683	CcSEcCtD
Nisoldipine—Chest pain—Epirubicin—urinary bladder cancer	0.000221	0.00068	CcSEcCtD
Nisoldipine—Myalgia—Epirubicin—urinary bladder cancer	0.000221	0.00068	CcSEcCtD
Nisoldipine—Arthralgia—Epirubicin—urinary bladder cancer	0.000221	0.00068	CcSEcCtD
Nisoldipine—Anxiety—Epirubicin—urinary bladder cancer	0.00022	0.000677	CcSEcCtD
Nisoldipine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000219	0.000673	CcSEcCtD
Nisoldipine—Discomfort—Epirubicin—urinary bladder cancer	0.000218	0.000672	CcSEcCtD
Nisoldipine—Malaise—Doxorubicin—urinary bladder cancer	0.000217	0.000666	CcSEcCtD
Nisoldipine—Dry mouth—Epirubicin—urinary bladder cancer	0.000216	0.000665	CcSEcCtD
Nisoldipine—Vertigo—Doxorubicin—urinary bladder cancer	0.000216	0.000664	CcSEcCtD
Nisoldipine—Anorexia—Methotrexate—urinary bladder cancer	0.000216	0.000664	CcSEcCtD
Nisoldipine—Syncope—Doxorubicin—urinary bladder cancer	0.000215	0.000662	CcSEcCtD
Nisoldipine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000215	0.000661	CcSEcCtD
Nisoldipine—Confusional state—Epirubicin—urinary bladder cancer	0.000214	0.000657	CcSEcCtD
Nisoldipine—Palpitations—Doxorubicin—urinary bladder cancer	0.000212	0.000653	CcSEcCtD
Nisoldipine—Oedema—Epirubicin—urinary bladder cancer	0.000212	0.000652	CcSEcCtD
Nisoldipine—Hypotension—Methotrexate—urinary bladder cancer	0.000212	0.000651	CcSEcCtD
Nisoldipine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000211	0.000649	CcSEcCtD
Nisoldipine—Cough—Doxorubicin—urinary bladder cancer	0.00021	0.000645	CcSEcCtD
Nisoldipine—Shock—Epirubicin—urinary bladder cancer	0.000208	0.000641	CcSEcCtD
Nisoldipine—Tachycardia—Epirubicin—urinary bladder cancer	0.000207	0.000636	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000206	0.000634	CcSEcCtD
Nisoldipine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000205	0.00063	CcSEcCtD
Nisoldipine—Insomnia—Methotrexate—urinary bladder cancer	0.000205	0.00063	CcSEcCtD
Nisoldipine—Chest pain—Doxorubicin—urinary bladder cancer	0.000204	0.000629	CcSEcCtD
Nisoldipine—Myalgia—Doxorubicin—urinary bladder cancer	0.000204	0.000629	CcSEcCtD
Nisoldipine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000204	0.000629	CcSEcCtD
Nisoldipine—Anxiety—Doxorubicin—urinary bladder cancer	0.000204	0.000627	CcSEcCtD
Nisoldipine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000203	0.000625	CcSEcCtD
Nisoldipine—Discomfort—Doxorubicin—urinary bladder cancer	0.000202	0.000621	CcSEcCtD
Nisoldipine—Anorexia—Epirubicin—urinary bladder cancer	0.000202	0.000621	CcSEcCtD
Nisoldipine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000202	0.000621	CcSEcCtD
Nisoldipine—Somnolence—Methotrexate—urinary bladder cancer	0.000201	0.000619	CcSEcCtD
Nisoldipine—Dry mouth—Doxorubicin—urinary bladder cancer	0.0002	0.000615	CcSEcCtD
Nisoldipine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000199	0.000613	CcSEcCtD
Nisoldipine—Hypotension—Epirubicin—urinary bladder cancer	0.000198	0.000609	CcSEcCtD
Nisoldipine—Confusional state—Doxorubicin—urinary bladder cancer	0.000198	0.000608	CcSEcCtD
Nisoldipine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000197	0.000605	CcSEcCtD
Nisoldipine—Oedema—Doxorubicin—urinary bladder cancer	0.000196	0.000603	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000193	0.000594	CcSEcCtD
Nisoldipine—Shock—Doxorubicin—urinary bladder cancer	0.000193	0.000593	CcSEcCtD
Nisoldipine—Insomnia—Epirubicin—urinary bladder cancer	0.000192	0.000589	CcSEcCtD
Nisoldipine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000191	0.000588	CcSEcCtD
Nisoldipine—Paraesthesia—Epirubicin—urinary bladder cancer	0.00019	0.000585	CcSEcCtD
Nisoldipine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000189	0.000583	CcSEcCtD
Nisoldipine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000189	0.000581	CcSEcCtD
Nisoldipine—Somnolence—Epirubicin—urinary bladder cancer	0.000188	0.000579	CcSEcCtD
Nisoldipine—Anorexia—Doxorubicin—urinary bladder cancer	0.000187	0.000575	CcSEcCtD
Nisoldipine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000187	0.000574	CcSEcCtD
Nisoldipine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000186	0.000574	CcSEcCtD
Nisoldipine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000184	0.000566	CcSEcCtD
Nisoldipine—Hypotension—Doxorubicin—urinary bladder cancer	0.000183	0.000563	CcSEcCtD
Nisoldipine—Urticaria—Methotrexate—urinary bladder cancer	0.00018	0.000553	CcSEcCtD
Nisoldipine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000179	0.00055	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000179	0.000549	CcSEcCtD
Nisoldipine—Insomnia—Doxorubicin—urinary bladder cancer	0.000177	0.000545	CcSEcCtD
Nisoldipine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000176	0.000541	CcSEcCtD
Nisoldipine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000175	0.000537	CcSEcCtD
Nisoldipine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000175	0.000537	CcSEcCtD
Nisoldipine—Somnolence—Doxorubicin—urinary bladder cancer	0.000174	0.000536	CcSEcCtD
Nisoldipine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000173	0.000531	CcSEcCtD
Nisoldipine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00017	0.000524	CcSEcCtD
Nisoldipine—Urticaria—Epirubicin—urinary bladder cancer	0.000168	0.000518	CcSEcCtD
Nisoldipine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000167	0.000515	CcSEcCtD
Nisoldipine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000167	0.000513	CcSEcCtD
Nisoldipine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000162	0.000497	CcSEcCtD
Nisoldipine—Pruritus—Methotrexate—urinary bladder cancer	0.00016	0.000493	CcSEcCtD
Nisoldipine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000156	0.00048	CcSEcCtD
Nisoldipine—Urticaria—Doxorubicin—urinary bladder cancer	0.000156	0.000479	CcSEcCtD
Nisoldipine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000155	0.000477	CcSEcCtD
Nisoldipine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000155	0.000476	CcSEcCtD
Nisoldipine—Pruritus—Epirubicin—urinary bladder cancer	0.00015	0.000461	CcSEcCtD
Nisoldipine—Dizziness—Methotrexate—urinary bladder cancer	0.00015	0.00046	CcSEcCtD
Nisoldipine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000145	0.000446	CcSEcCtD
Nisoldipine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000144	0.000444	CcSEcCtD
Nisoldipine—Rash—Methotrexate—urinary bladder cancer	0.000143	0.000439	CcSEcCtD
Nisoldipine—Dermatitis—Methotrexate—urinary bladder cancer	0.000143	0.000439	CcSEcCtD
Nisoldipine—Headache—Methotrexate—urinary bladder cancer	0.000142	0.000436	CcSEcCtD
Nisoldipine—Dizziness—Epirubicin—urinary bladder cancer	0.00014	0.000431	CcSEcCtD
Nisoldipine—Pruritus—Doxorubicin—urinary bladder cancer	0.000139	0.000427	CcSEcCtD
Nisoldipine—Nausea—Methotrexate—urinary bladder cancer	0.000134	0.000414	CcSEcCtD
Nisoldipine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000134	0.000413	CcSEcCtD
Nisoldipine—Rash—Epirubicin—urinary bladder cancer	0.000134	0.000411	CcSEcCtD
Nisoldipine—Dermatitis—Epirubicin—urinary bladder cancer	0.000133	0.00041	CcSEcCtD
Nisoldipine—Headache—Epirubicin—urinary bladder cancer	0.000133	0.000408	CcSEcCtD
Nisoldipine—Dizziness—Doxorubicin—urinary bladder cancer	0.00013	0.000399	CcSEcCtD
Nisoldipine—Nausea—Epirubicin—urinary bladder cancer	0.000126	0.000387	CcSEcCtD
Nisoldipine—Rash—Doxorubicin—urinary bladder cancer	0.000124	0.00038	CcSEcCtD
Nisoldipine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000123	0.00038	CcSEcCtD
Nisoldipine—Headache—Doxorubicin—urinary bladder cancer	0.000123	0.000378	CcSEcCtD
Nisoldipine—Nausea—Doxorubicin—urinary bladder cancer	0.000116	0.000358	CcSEcCtD
Nisoldipine—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	8.66e-05	0.000715	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	8.61e-05	0.00071	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	8.56e-05	0.000706	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	8.56e-05	0.000706	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	8.52e-05	0.000703	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—EGFR—urinary bladder cancer	8.49e-05	0.000701	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	8.49e-05	0.0007	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.4e-05	0.000693	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—EP300—urinary bladder cancer	8.3e-05	0.000684	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—ERBB2—urinary bladder cancer	8.28e-05	0.000683	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	8.21e-05	0.000677	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NAT1—urinary bladder cancer	8.21e-05	0.000677	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—ENO2—urinary bladder cancer	8.13e-05	0.00067	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—HPGDS—urinary bladder cancer	8.13e-05	0.00067	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	8.08e-05	0.000667	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—SRC—urinary bladder cancer	8.07e-05	0.000666	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—SRC—urinary bladder cancer	8.06e-05	0.000665	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—EGFR—urinary bladder cancer	8.04e-05	0.000664	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—KRAS—urinary bladder cancer	8.02e-05	0.000662	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—HRAS—urinary bladder cancer	7.96e-05	0.000656	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GSTT1—urinary bladder cancer	7.88e-05	0.00065	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—NQO1—urinary bladder cancer	7.87e-05	0.000649	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—RHOA—urinary bladder cancer	7.86e-05	0.000649	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	7.83e-05	0.000646	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.8e-05	0.000643	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.72e-05	0.000637	CbGpPWpGaD
Nisoldipine—CACNB2—Neuronal System—HRAS—urinary bladder cancer	7.69e-05	0.000634	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—KRAS—urinary bladder cancer	7.6e-05	0.000627	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	7.51e-05	0.00062	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—MMP9—urinary bladder cancer	7.5e-05	0.000619	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—NQO1—urinary bladder cancer	7.45e-05	0.000615	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—ERBB2—urinary bladder cancer	7.28e-05	0.0006	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	7.21e-05	0.000595	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	7.14e-05	0.000589	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	7.11e-05	0.000587	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—EP300—urinary bladder cancer	7.11e-05	0.000587	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—MMP9—urinary bladder cancer	7.1e-05	0.000586	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	7.08e-05	0.000584	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—EGFR—urinary bladder cancer	7.07e-05	0.000583	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—EGFR—urinary bladder cancer	7.07e-05	0.000583	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	6.95e-05	0.000574	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—SRC—urinary bladder cancer	6.92e-05	0.000571	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—TYMP—urinary bladder cancer	6.88e-05	0.000568	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—HRAS—urinary bladder cancer	6.82e-05	0.000563	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	6.76e-05	0.000558	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—EP300—urinary bladder cancer	6.74e-05	0.000556	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—TNF—urinary bladder cancer	6.73e-05	0.000556	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—KRAS—urinary bladder cancer	6.68e-05	0.000551	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—KRAS—urinary bladder cancer	6.68e-05	0.000551	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.57e-05	0.000542	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GSTP1—urinary bladder cancer	6.56e-05	0.000542	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—NQO1—urinary bladder cancer	6.55e-05	0.00054	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—SRC—urinary bladder cancer	6.55e-05	0.00054	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	6.54e-05	0.000539	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.48e-05	0.000535	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—HRAS—urinary bladder cancer	6.46e-05	0.000533	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	6.39e-05	0.000527	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—MMP9—urinary bladder cancer	6.24e-05	0.000515	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NAT2—urinary bladder cancer	6.22e-05	0.000514	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	6.22e-05	0.000513	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GSTP1—urinary bladder cancer	6.22e-05	0.000513	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	6.21e-05	0.000512	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	6.2e-05	0.000511	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NAT1—urinary bladder cancer	6.2e-05	0.000511	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	6.13e-05	0.000506	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—TYMS—urinary bladder cancer	6.1e-05	0.000504	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—EGFR—urinary bladder cancer	6.06e-05	0.0005	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	6.04e-05	0.000498	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GSTM1—urinary bladder cancer	6.03e-05	0.000498	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—NCOR1—urinary bladder cancer	6.03e-05	0.000498	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.96e-05	0.000492	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—EP300—urinary bladder cancer	5.92e-05	0.000488	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—TYMS—urinary bladder cancer	5.78e-05	0.000477	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GPX1—urinary bladder cancer	5.78e-05	0.000477	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—TNF—urinary bladder cancer	5.77e-05	0.000476	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—SRC—urinary bladder cancer	5.75e-05	0.000475	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—EGFR—urinary bladder cancer	5.74e-05	0.000474	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—KRAS—urinary bladder cancer	5.73e-05	0.000472	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—NCOR1—urinary bladder cancer	5.71e-05	0.000471	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GSTM1—urinary bladder cancer	5.71e-05	0.000471	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—HRAS—urinary bladder cancer	5.68e-05	0.000468	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—HRAS—urinary bladder cancer	5.68e-05	0.000468	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—ERCC2—urinary bladder cancer	5.67e-05	0.000468	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	5.67e-05	0.000468	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GPX1—urinary bladder cancer	5.47e-05	0.000451	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—TNF—urinary bladder cancer	5.47e-05	0.000451	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GSTP1—urinary bladder cancer	5.46e-05	0.000451	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—KRAS—urinary bladder cancer	5.42e-05	0.000447	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—RRM2—urinary bladder cancer	5.37e-05	0.000443	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—ERCC2—urinary bladder cancer	5.37e-05	0.000443	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—MTHFR—urinary bladder cancer	5.33e-05	0.00044	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.27e-05	0.000435	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	5.22e-05	0.00043	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.2e-05	0.000429	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	5.1e-05	0.000421	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	5.08e-05	0.000419	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—TYMS—urinary bladder cancer	5.08e-05	0.000419	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—MTHFR—urinary bladder cancer	5.05e-05	0.000417	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—EGFR—urinary bladder cancer	5.04e-05	0.000416	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GSTM1—urinary bladder cancer	5.02e-05	0.000414	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—NCOR1—urinary bladder cancer	5.02e-05	0.000414	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	4.98e-05	0.000411	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—ENO2—urinary bladder cancer	4.98e-05	0.000411	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	4.97e-05	0.00041	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.95e-05	0.000408	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.95e-05	0.000408	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—HRAS—urinary bladder cancer	4.87e-05	0.000402	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.86e-05	0.000401	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	4.83e-05	0.000398	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	4.82e-05	0.000398	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GPX1—urinary bladder cancer	4.81e-05	0.000397	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—TNF—urinary bladder cancer	4.8e-05	0.000396	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—KRAS—urinary bladder cancer	4.76e-05	0.000393	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—ERCC2—urinary bladder cancer	4.72e-05	0.000389	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	4.7e-05	0.000387	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—HRAS—urinary bladder cancer	4.61e-05	0.00038	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.59e-05	0.000379	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.52e-05	0.000373	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	4.5e-05	0.000371	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.44e-05	0.000367	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—MTHFR—urinary bladder cancer	4.44e-05	0.000366	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.43e-05	0.000366	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PPARG—urinary bladder cancer	4.32e-05	0.000357	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.23e-05	0.000349	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CREBBP—urinary bladder cancer	4.15e-05	0.000343	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.11e-05	0.000339	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PPARG—urinary bladder cancer	4.09e-05	0.000338	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	4.07e-05	0.000336	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—HRAS—urinary bladder cancer	4.05e-05	0.000334	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.03e-05	0.000332	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NQO1—urinary bladder cancer	4.01e-05	0.000331	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CREBBP—urinary bladder cancer	3.93e-05	0.000325	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	3.88e-05	0.00032	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.85e-05	0.000317	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.82e-05	0.000315	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.82e-05	0.000315	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.75e-05	0.00031	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.75e-05	0.000309	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.68e-05	0.000304	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.6e-05	0.000297	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PPARG—urinary bladder cancer	3.6e-05	0.000297	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	3.6e-05	0.000297	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	3.6e-05	0.000297	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.49e-05	0.000288	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	3.49e-05	0.000288	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CREBBP—urinary bladder cancer	3.46e-05	0.000285	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.43e-05	0.000283	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.4e-05	0.000281	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PTGS2—urinary bladder cancer	3.4e-05	0.000281	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.39e-05	0.00028	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	3.35e-05	0.000276	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PTGS2—urinary bladder cancer	3.22e-05	0.000266	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.14e-05	0.000259	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	3.11e-05	0.000257	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	3.07e-05	0.000254	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	3.07e-05	0.000254	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.03e-05	0.00025	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.01e-05	0.000248	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3e-05	0.000247	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.97e-05	0.000245	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PTEN—urinary bladder cancer	2.97e-05	0.000245	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	2.94e-05	0.000243	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.93e-05	0.000242	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.9e-05	0.000239	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.89e-05	0.000239	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	2.89e-05	0.000238	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.88e-05	0.000237	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PTGS2—urinary bladder cancer	2.83e-05	0.000233	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—EP300—urinary bladder cancer	2.83e-05	0.000233	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PTEN—urinary bladder cancer	2.81e-05	0.000232	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	2.72e-05	0.000224	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.71e-05	0.000224	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.71e-05	0.000224	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.71e-05	0.000224	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—EP300—urinary bladder cancer	2.68e-05	0.000221	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.63e-05	0.000217	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PTEN—urinary bladder cancer	2.47e-05	0.000204	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.46e-05	0.000203	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	2.42e-05	0.0002	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—EP300—urinary bladder cancer	2.35e-05	0.000194	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.34e-05	0.000193	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.31e-05	0.000191	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	2.25e-05	0.000185	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	2.22e-05	0.000183	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	2.22e-05	0.000183	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	2.2e-05	0.000182	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.19e-05	0.00018	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.17e-05	0.000179	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.17e-05	0.000179	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.15e-05	0.000178	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	2.13e-05	0.000176	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	2.12e-05	0.000175	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.1e-05	0.000173	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.09e-05	0.000173	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	2.09e-05	0.000172	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.07e-05	0.000171	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.96e-05	0.000162	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.82e-05	0.000151	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.81e-05	0.000149	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.75e-05	0.000144	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.73e-05	0.000143	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.7e-05	0.00014	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.69e-05	0.00014	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.68e-05	0.000138	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.68e-05	0.000138	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.67e-05	0.000138	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.67e-05	0.000138	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.62e-05	0.000134	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.61e-05	0.000132	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.59e-05	0.000131	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.58e-05	0.00013	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.53e-05	0.000126	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	1.51e-05	0.000125	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.48e-05	0.000122	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.48e-05	0.000122	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.46e-05	0.00012	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.44e-05	0.000119	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.41e-05	0.000116	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.35e-05	0.000112	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.35e-05	0.000111	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.34e-05	0.00011	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.34e-05	0.00011	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.28e-05	0.000106	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.26e-05	0.000104	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.25e-05	0.000103	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.2e-05	9.91e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.18e-05	9.76e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.15e-05	9.52e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.12e-05	9.28e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.09e-05	9.01e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.05e-05	8.62e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.04e-05	8.6e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.03e-05	8.52e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.03e-05	8.52e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.89e-06	8.16e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.71e-06	8.01e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	9.59e-06	7.91e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	9.45e-06	7.8e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	9.22e-06	7.6e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	9.13e-06	7.53e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PTEN—urinary bladder cancer	8.24e-06	6.8e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—EP300—urinary bladder cancer	7.86e-06	6.49e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	7.55e-06	6.23e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.4e-06	6.11e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.11e-06	5.87e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	6.58e-06	5.43e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—EP300—urinary bladder cancer	6.28e-06	5.18e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.82e-06	4.81e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.08e-06	4.19e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.84e-06	4e-05	CbGpPWpGaD
